Please login to the form below

Not currently logged in
Email:
Password:

Amgen finance VP joins True North Therapeutics

Pamela Wapnick appointed as chief financial officer

California-based True North Therapeutics has appointed Pamela Wapnick as its new chief financial officer.

Wapnick joins the rare diseases clinical stage biopharmaceutical company from Amgen, where she most recently served as vice president of finance.

Prior to this, Wapnick had corporate finance responsibility for Amgen's global research and development activities, and has served as vice president and treasurer of Amgen.

She brings over 25 years of international business and finance experience to True North, including senior financial management positions at Delphi Corporation, Federal Mogul Corporation and General Motors Corporation.

Nancy Stagliano, chief executive officer of True North, said: “I am pleased to announce Pam's appointment to the position of chief financial officer as a member of our management team.

“Her breadth of experience in corporate finance and treasury within the biotechnology industry, including nearly 10 years and Amgen, will serve us well as we continue to advance True North's pipeline of novel product candidates.”

3rd August 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics